{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T23:58:29Z","timestamp":1772927909983,"version":"3.50.1"},"reference-count":32,"publisher":"Japan Oil Chemists' Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Oleo Sci."],"published-print":{"date-parts":[[2026]]},"DOI":"10.5650\/jos.ess25220","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T22:13:44Z","timestamp":1772316824000},"page":"239-250","source":"Crossref","is-referenced-by-count":0,"title":["Instillation of Hesperetin Nanosuspensions Prevent Lens Opacification in Selenite-Induced Cataract Rats"],"prefix":"10.5650","volume":"75","author":[{"given":"Yu","family":"Mano","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, Kindai University, 3-4-1 Kowakae, Higashi-Osaka, Osaka, 577-8502, JAPAN"},{"name":"Department of Pharmacy, Bell Land General Hospital, 500-3, Higashiyama, Naka-ku, Sakai, Osaka, 599-8247, JAPAN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryotaro","family":"Kuwamura","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Kindai University, 3-4-1 Kowakae, Higashi-Osaka, Osaka, 577-8502, JAPAN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Otake","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Kindai University, 3-4-1 Kowakae, Higashi-Osaka, Osaka, 577-8502, JAPAN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Ogata","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Kindai University, 3-4-1 Kowakae, Higashi-Osaka, Osaka, 577-8502, JAPAN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju","family":"Misra","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Pharm. Technology, L. M. College of Pharmacy, Navrangpura, Ahmedabad, Gujarat, 380009, INDIA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norio","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Okamoto Eye Clinic, 5-11-12-312, Izumi-Cho, Suita, Osaka, 564-0041, JAPAN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Tsubaki","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacotherapy, Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, 1314-1 Shido, Sanuki, Kagawa 769-2193, JAPAN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Kindai University, 3-4-1 Kowakae, Higashi-Osaka, Osaka, 577-8502, JAPAN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1266-038X","authenticated-orcid":false,"given":"Noriaki","family":"Nagai","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Kindai University, 3-4-1 Kowakae, Higashi-Osaka, Osaka, 577-8502, JAPAN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3621","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Truscott R.J.W. Age-related nuclear cataract-oxidation is the key. Exp. Eye Res. 80, 709-725 (2005). doi: 10.1016\/j.exer.2004.12.007","DOI":"10.1016\/j.exer.2004.12.007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Spector, A. Oxidative stress-induced cataract: mechanism of action. FASEB J. 9, 1173-1182 (1995).","DOI":"10.1096\/fasebj.9.12.7672510"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3) Asha, R.; Gayathri Devi, V.; Abraham, A. Lupeol, a pentacyclic triterpenoid isolated from Vernonia cinerea attenuate selenite induced cataract formation in Sprague Dawley rat pups. Chem. Biol. Interact. 245, 20-29 (2016). doi: 10.1016\/j.cbi.2015.12.002","DOI":"10.1016\/j.cbi.2015.12.002"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4) Njie-Mbye, Y.F.; Kulkarni-Chitnis M; Opere, C.A.; Barrett, A.; Ohia, S.E. Lipid peroxidation: pathophysiological and pharmacological implications in the eye. Front. Physiol. 4, 366 (2013). doi: 10.3389\/fphys.2013.00366","DOI":"10.3389\/fphys.2013.00366"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5) Kaur, J.; Kukreja, S.; Kaur, A.; Malhotra, N.; Kaur, R. The oxidative stress in cataract patients. J. Clin. Diagn. Res. 6, 1629-1632 (2012). doi: 10.7860\/JCDR\/2012\/4856.2626","DOI":"10.7860\/JCDR\/2012\/4856.2626"},{"key":"6","unstructured":"6) Gao, S.; Qin, T.; Liu, Z.; Caceres, M.A.; Ronchi, C.F. et al. Lutein and zeaxanthin supplementation reduces H<sub>2<\/sub>O<sub>2<\/sub>-induced oxidative damage in human lens epithelial cells. Mol. Vis. 17, 3180-3190 (2011)."},{"key":"7","doi-asserted-by":"publisher","unstructured":"7) Manikandan, R.; Thiagarajan, R.; Beulaja, S.; Sudhandiran, G.; Arumugam, M. Effect of curcumin on selenite-induced cataractogenesis in Wistar rat pups. Curr. Eye Res. 35, 122-129 (2010). doi: 10.3109\/02713680903447884","DOI":"10.3109\/02713680903447884"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8) Hwang, S.L.; Yen, G.C. Modulation of Akt, JNK, and p38 activation is involved in citrus flavonoid-mediated cytoprotection of PC12 cells challenged by hydrogen peroxide. J. Agric. Food Chem. 57, 2576-2582 (2009). doi: 10.1021\/jf8033607","DOI":"10.1021\/jf8033607"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9) Emim, J.A.; Oliveira, A.B.; Lapa, A.J. Pharmacological evaluation of the anti-inflammatory activity of a citrus bioflavonoid, hesperidin, and the isoflavonoids, duartin and claussequinone, in rats and mice. J. Pharm. Pharmacol. 46, 118-122 (1994). doi: 10.1111\/j.2042-7158.1994.tb03753.x","DOI":"10.1111\/j.2042-7158.1994.tb03753.x"},{"key":"10","unstructured":"10) Nakazawa, Y.; Oka, M.; Bando, M.; Takehara, M. Hesperetin prevents selenite-induced cataract in rats. Mol. Vis. 21, 804-810 (2015)."},{"key":"11","doi-asserted-by":"publisher","unstructured":"11) Alu&apos;datt, M.H.; Rababah, T.; Alhamad, M.N.; Al-Mahasneh, M.A.; Ereifej, K. et al. Profiles of free and bound phenolics extracted from Citrus fruits and their roles in biological systems: Content, and antioxidant, anti-diabetic and anti-hypertensive properties. Food Funct. 8, 3187-3197 (2017). doi: 10.1039\/c7fo00212b","DOI":"10.1039\/C7FO00212B"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12) Akiyama, S.; Katsumata, S.; Suzuki, K.; Nakaya, Y.; Ishimi, Y. et al. Hypoglycemic and hypolipidemic effects of hesperidin and cyclodextrin-clathrated hesperetin in Goto-Kakizaki rats with type 2 diabetes. Biosci. Biotechnol. Biochem. 73, 2779-2782 (2009). doi: 10.1271\/bbb.90576","DOI":"10.1271\/bbb.90576"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13) Miwa, Y.; Mitsuzumi, H.; Sunayama, T.; Yamada, M.; Okada, K. et al. Glucosyl hesperidin lowers serum triglyceride level in hypertriglyceridemic subjects through the improvement of very low-density lipoprotein metabolic abnormality. J. Nutr. Sci. Vitaminol. (Tokyo) 51, 460-470 (2005). doi: 10.3177\/jnsv.51.460","DOI":"10.3177\/jnsv.51.460"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14) Nakazawa, Y.; Oka, M.; Tamura, H.; Takehana, M. Effect of hesperetin on chaperone activity in selenite-induced cataract. Open Med. (Wars) 11, 183-189 (2016). doi: 10.1515\/med-2016-0035","DOI":"10.1515\/med-2016-0035"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15) Cholkar, K.; Patel, S.P.; Vadlapudi, A.D.; Mitra, A.K. Novel strategies for anterior segment ocular drug delivery. J. Ocul. Pharmacol. Ther. 29, 106-123 (2013). doi: 10.1089\/jop.2012.0200","DOI":"10.1089\/jop.2012.0200"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16) Lee, V.H.; Robinson, J.R. Topical ocular drug delivery: recent developments and future challenges. J. Ocul. Pharmacol. 2, 67-108 (1986). doi: 10.1089\/jop.1986.2.67","DOI":"10.1089\/jop.1986.2.67"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17) Mofidfar, M.; Abdi, B.; Ahadian, S.; Mostafavi, E.; Desai, T.A. et al. Drug delivery to the anterior segment of the eye: A review of current and future treatment strategies. Int. J. Pharm., 607, 120924 (2021). doi: 10.1016\/j.ijpharm.2021.120924","DOI":"10.1016\/j.ijpharm.2021.120924"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18) Liu, S.; Jones, L.; Gu F.X. Nanomaterials for ocular drug delivery. Macromol. Biosci. 12, 608-620 (2012). doi: 10.1002\/mabi.201100419","DOI":"10.1002\/mabi.201100419"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19) Mandal, A.; Gote, V.; Pal, D.; Ogundele, A.; Mitra, A.K. Ocular pharmacokinetics of a topical ophthalmic nanomicellar solution of cyclosporine (Cequa<sup>\u00ae<\/sup>) for dry eye disease. Pharm. Res. 36, 36 (2019). doi: 10.1007\/s11095-018-2556-5","DOI":"10.1007\/s11095-018-2556-5"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20) Bachu, R.D.; Chowdhury, P.; Al-Saedi, Z.H.F.; Karla, P.K.; Boddu, S.H.S. Ocular drug delivery barriers-role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics 10, 28 (2018). doi: 10.3390\/pharmaceutics10010028","DOI":"10.3390\/pharmaceutics10010028"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21) Seyfoddin, A.; Shaw, J.; Al-Kassas, R. Solid lipid nanoparticles for ocular drug delivery. Drug Deliv. 17, 467-489 (2010). doi: 10.3109\/10717544.2010.483257","DOI":"10.3109\/10717544.2010.483257"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22) Stewart, S.A.; Dom\u00ednguez-Robles, J.; Donnelly, R.F.; Larra\u00f1eta, E, Implantable polymeric drug delivery devices: classification, manufacture, materials, and clinical applications. Polymers (Basel) 10, 1379 (2018). doi: 10.3390\/polym10121379","DOI":"10.3390\/polym10121379"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23) Shrestha, H.; Bala, R.; Arora, S. Lipid-based drug delivery systems. J. Pharm. (Cairo) 2014, 801820 (2014). doi: 10.1155\/2014\/801820","DOI":"10.1155\/2014\/801820"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24) Gunda, S.; Hariharan, S.; Mitra, A.K. Corneal absorption and anterior chamber pharmacokinetics of dipeptide monoester prodrugs of ganciclovir (GCV): in vivo comparative evaluation of these prodrugs with Val-GCV and GCV in rabbits. J. Ocul. Pharmacol. Ther. 22, 465-476 (2006). doi: 10.1089\/jop.2006.22.465","DOI":"10.1089\/jop.2006.22.465"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25) Vaka, S.R.K.; Sammeta, S.M.; Day, L.B.; Murthy, S.N. Transcorneal iontophoresis for delivery of ciprofloxacin hydrochloride. Curr. Eye Res. 33, 661-667 (2008). doi: 10.1080\/02713680802270945","DOI":"10.1080\/02713680802270945"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26) Fangueiro, J.F.; Veiga, F.; Silva, A.M.; Souto, E.B. Ocular drug delivery \u2013 new strategies for targeting anterior and posterior segments of the eye. Curr. Pharm. Des. 22, 1135-1146 (2016). doi: 10.2174\/1381612822666151216145900","DOI":"10.2174\/1381612822666151216145900"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27) Nagai, N.; Ogata, F.; Otake, H.; Nakazawa, Y.; Kawasaki, N. Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles. Int. J. Nanomedicine 14, 1213-1227 (2019). doi: 10.2147\/IJN.S196681","DOI":"10.2147\/IJN.S196681"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28) Nagai, N.; Ito, Y.; Okamoto, N.; Shimomura, Y. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability. Toxicology 319, 53-62 (2014). doi: 10.1016\/j.tox.2014.02.012","DOI":"10.1016\/j.tox.2014.02.012"},{"key":"29","unstructured":"29) Shearer, T.R.; Ma, H.; Fukiage, C.; Azuma, M. Selenite nuclear cataract: Review of the model. Mol. Vis. 3, 8 (1997)."},{"key":"30","doi-asserted-by":"publisher","unstructured":"30) David, L.L.; Shearer, T.R. Beta-crystallins insolubilized by calpain II in vitro contain cleavage sites similar to beta-crystallins insolubilized during cataract. FEBS Lett. 324, 265-270 (1993). doi: 10.1016\/0014-5793(93)80131-d","DOI":"10.1016\/0014-5793(93)80131-D"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31) Sasikala, V.; Rooban, B.N.; Sahasranamam, V.; Abraham, A. Rutin ameliorates free radical mediated cataract by enhancing the chaperone activity of alpha-crystallin. Graefes. Arch. Clin. Exp. Ophthalmol. 251, 1747-1755 (2013). doi: 10.1007\/s00417-013-2281-z","DOI":"10.1007\/s00417-013-2281-z"},{"key":"32","unstructured":"32) Rooban, B.N.; Sasikala, V.; Sahasranamam, V.; Abraham, A. Analysis on the alterations of lens proteins by Vitex negundo in selenite cataract models. Mol. Vis. 17, 1239-1248 (2011)."}],"container-title":["Journal of Oleo Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jos\/75\/3\/75_jos.ess25220\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:17:21Z","timestamp":1772857041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jos\/75\/3\/75_jos.ess25220\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5650\/jos.ess25220","relation":{},"ISSN":["1345-8957","1347-3352"],"issn-type":[{"value":"1345-8957","type":"print"},{"value":"1347-3352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"jos.ess25220"}}